Objective: To observe the clinical efficacy of Fangji Huangqi Tang combined with Zhenwutang for chronic heart failure (Qi deficiency and blood stasis type). Method: According to the inclusion criteria

80 patients with chronic heart failure (Qi deficiency and blood stasis type) were randomly divided into control group and treatment group (40 cases in each group). The patients in control group received conventional anti-heart failure western medicine (including angiotensin converting enzyme inhibitors or angiotensin Ⅱ receptor blockers

vasodilator drugs

beta blockers

diuretics

digoxin

et al); patients in treatment group received Fangji Huangqi Tang combined with Zhenwutang on the basis of routine treatment

for a total of 4 weeks. Two groups of patients were observed before and after treatment for traditional Chinese medicine (TCM) syndrome curative effect

cardiac function grading

left ventricular end diastolic diameter (LVED)

left ventricular end systolic diameter (LVSD)

and left ventricular ejection fraction (LVEF). Result: After treatment

the total effective rate for TCM syndrome was 82.5% in treatment group

better than 65% in control group (P <0.05); the total effective rate of cardiac functions grading was 85% in treatment group

better than the 60% in control group (P <0.05); in the index of heart function

LVED and LVSD levels were decreased

and LVEF was increased in both treatment group and control group after treatment (P <0.05); the LVED and LVSD levels in treatment group were lower while LVEF was higher than those in the control group (P <0.01). Conclusion: Fangji Huangqi Tang combined with Zhenwutang has a certain role in improving TCM syndrome

cardiac functions grading

cardiac functions and ventricular remodeling in patients with chronic heart failures.